FOLH1 and neoplasm: No activity was added to the background when imaging the NEMA phantom, based on the assumption that a high tumour to background contrast will be seen in patients treated with 212Pb-NG001, as has been observed in imaging studies with gallium-68-labelled PSMA [40].